£149.63

Springer Pediatric Cancer, Volume 4: Diagnosis, Therapy, and Prognosis

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£150 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days • 90 data points

Historical
Generating forecast...
£150.58 £149.54 £149.76 £149.99 £150.22 £150.45 £150.68 18 February 2026 12 March 2026 03 April 2026 25 April 2026 18 May 2026

Price Distribution

Price distribution over 90 days • 2 price levels

Days at Price
Current Price
88 days · current 2 days 0 22 44 66 88 £150 £151 Days at Price

Price Analysis

Most common price: £150 (88 days, 97.8%)

Price range: £150 - £151

Price levels: 2 different prices over 90 days

Description

Product Description This book focuses on brain tumors, the most common tumors and the leading cause of cancer-related death in children. The contents are organized in seven sections: Neuroblastoma, Medulloblastoma, Leukemia, Lymphoma, Rhabdoid, Sarcoma and Miscellaneous Tumors. From the Back Cover This entry in the series Pediatric Cancer offers comprehensive information on a variety of cancers, concentrating on brain tumors, the most common solid tumors and the leading cause of cancer-related mortality in children. The contents are organized in seven sections: Neuroblastoma, Medulloblastoma, Leukemia, Lymphoma, Rhabdoid, Sarcoma and Miscellaneous Tumors. Coverage includes pediatric medulloblastoma, and treatments including craniospinal radiation followed by adjuvant chemotherapy. The contributors explain diagnosis and chemotherapy of children with acute lymphoblastic leukemia, and diagnosis of bone marrow involvement in pediatric lymphoma patients. Ewing’s sarcoma, a highly malignant connective tissue neoplasm formed by the proliferation of mesenchymal cells, receives extensive coverage, including targeting of molecular pathways and chemotherapy and surgical treatment. The roles of apoptotic genes, MYCN gene, MDM2, and SNP309, P13K inhibitors, alternative splicing and microRNAs, activated leukocyte cell adhesion molecule and inhibition by alu-like RNA in neuroblastoma are discussed in detail. The book explores the molecular genetics, diagnosis, prognosis and therapy of the atypical teratoid/rhabdoid tumor (AT/RT). Among the most common malignant neoplasms in children, AT/RT exhibits similarities with other CNS tumors, which can lead to misclassification, as pointed out in the book. The contributors discuss diagnosis of AT/RT type using imaging technology, and describe new strategies, including intensive multimodal therapy and high dose chemotherapy with autologous stem cell transplantation that have shown improved outcomes. Coverage of therapies includes total resection followed by aggressive chemotherapy and radiation. Discussion includes diagnosis and treatment of other pediatric tumors including adrenocortical tumors, supratentorial primitive neuroectodermal tumors, giant midline tumors, gastrointestinal stromal tumors, ependymomas and intramedullary cavernoma. Pediatric Cancer: Diagnosis, Therapy and Prognosis, Volume 4 includes contributions by ninety-one contributors - oncologists, neurosurgeons, physicians, research scientists and pathologists - representing thirteen countries. The editor, M.A. Hayat, is a Distinguished Professor in the Department of Biological Sciences at Kean University, Union, New Jersey, USA.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Pediatric Neuro-oncology
87% match

Pediatric Neuro-oncology

Springer

£103.24 18 May 2026
Pediatric Oncology: A Comprehensive Guide
85% match

Pediatric Oncology: A Comprehensive Guide

Springer

£64.80 04 May 2026
Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach (Pediatric Oncology)
84% match

Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach (Pediatric Oncology)

Springer

£104.18 17 May 2026
Oncology of CNS Tumors
84% match

Oncology of CNS Tumors

Springer

£179.99 18 May 2026
Retinoblastoma (Pediatric Oncology)
83% match

Retinoblastoma (Pediatric Oncology)

Springer

£140.56 18 May 2026
Neonatal Tumours
83% match

Neonatal Tumours

Springer

£77.89 18 May 2026
Cancer in Children, Second Revised and Enlarge Edition: Clinical Management (UICC Current Treatment of Cancer)
83% match

Cancer in Children, Second Revised and Enlarge Edition: Clinical Management (UICC Current Treatment of Cancer)

Springer

£89.99 17 May 2026
Tumours of the Brain
82% match

Tumours of the Brain

Springer

£76.38 18 May 2026
Pediatric Oncology, An Issue of Surgical Oncology Clinics of North America (Volume 35-4) (The Clinics: Surgery, Volume 35-4)
82% match

Pediatric Oncology, An Issue of Surgical Oncology Clinics of North America (Volume 35-4) (The Clinics: Surgery, Volume 35-4)

Elsevier

£77.99 11 May 2026
Drug Therapy and Interactions in Pediatric Oncology: A Pocket Guide
81% match

Drug Therapy and Interactions in Pediatric Oncology: A Pocket Guide

Springer

£83.97 11 May 2026
Childhood Acute Lymphoblastic Leukemia
81% match

Childhood Acute Lymphoblastic Leukemia

Springer

£91.92 11 May 2026
Primary Bone Tumors and Tumorous Conditions in Children: Pathologic and Radiologic Diagnosis
81% match

Primary Bone Tumors and Tumorous Conditions in Children: Pathologic and Radiologic Diagnosis

Springer

£77.89 11 May 2026
Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)
81% match

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Springer

£148.53 18 May 2026
Clinical Ophthalmic Oncology: Retinoblastoma
81% match

Clinical Ophthalmic Oncology: Retinoblastoma

Springer

£70.21 04 May 2026
Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)
81% match

Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)

Springer

£149.64 18 May 2026
Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)
80% match

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Springer

£163.15 18 May 2026
Brain Tumors: 158 (Neuromethods, 158)
80% match

Brain Tumors: 158 (Neuromethods, 158)

Springer

£148.63 11 May 2026
Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)
80% match

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Springer

£113.76 18 May 2026
Tumor Dormancy, Quiescence, and Senescence, Volume 2: Aging, Cancer, and Noncancer Pathologies (Tumor Dormancy and Cellular Quiescence and Senescence, 2)
80% match

Tumor Dormancy, Quiescence, and Senescence, Volume 2: Aging, Cancer, and Noncancer Pathologies (Tumor Dormancy and Cellular Quiescence and Senescence, 2)

Springer

£107.98 18 May 2026
Oncologic Therapies
80% match

Oncologic Therapies

Springer

£81.58 18 May 2026
Atlas of Brain and Spine Oncology Imaging (Atlas of Oncology Imaging)
80% match

Atlas of Brain and Spine Oncology Imaging (Atlas of Oncology Imaging)

Springer

£80.64 18 May 2026
Neuro-Oncology: 66 (Developments in Oncology, 66)
80% match

Neuro-Oncology: 66 (Developments in Oncology, 66)

Springer

£76.38 18 May 2026
Orthopaedic Oncology: Primary and Metastatic Tumors of the Skeletal System: 162 (Cancer Treatment and Research, 162)
80% match

Orthopaedic Oncology: Primary and Metastatic Tumors of the Skeletal System: 162 (Cancer Treatment and Research, 162)

Springer

£73.10 18 May 2026
80% match

Advances in Brain Tumor Therapy: From Molecular Mechanisms to Clinical Practice

Academic Press

£137.99 11 May 2026